<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" 
	xmlns:cc="http://web.resource.org/cc/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" >

<channel>
<title>NeuroScene</title>
<link>http://neuroscene.com</link>
<description>Exploring the Future of Neuroscience</description>
<language>en</language>
<copyright>NeuroScene 2004-2007</copyright>
<managingEditor>srhernan@gmail.com</managingEditor>
<generator>Liberated Syndication - libsyn.com</generator>
<webMaster>podcasts@libsyn.com (Liberated Syndication)</webMaster>
<lastBuildDate>Fri, 30 May 2008 05:02:00 GMT</lastBuildDate>
<ttl>180</ttl>
<itunes:subtitle>NeuroScene - Exploring the Future of Neuroscience</itunes:subtitle>
<itunes:summary>Welcome to NeuroScene, where we explore the future of neuroscience...

NeuroScene is the producer of the groundbreaking podcast series &#34;Innovators in Neuroscience&#34; which is syndicated globally on the World Wide Web.  Since 2004, we have been providing readers and site visitors with the most comprehensive, cutting-edge information on the key trends and the hottest new developments within this industry space.  From breaking news stories to in-depth special reports, NeuroScene gives you the inside word on one of science's most fascinating frontiers. </itunes:summary>
<itunes:category text="Science &amp; Medicine" />
<itunes:category text="Science &amp; Medicine">
	<itunes:category text="Social Sciences" />
</itunes:category>
<itunes:category text="Science &amp; Medicine">
	<itunes:category text="Natural Sciences" />
</itunes:category>
<itunes:keywords>neuroscience, brain, mind, medicine, technology, cybernetics</itunes:keywords>
<itunes:author>NeuroScene</itunes:author>
<itunes:owner>
<itunes:email>steve@neuroscene.com</itunes:email>
<itunes:name>Stephen Hernan</itunes:name>
</itunes:owner>
<itunes:image href="http://libsyn.com/podcasts/neuroscene/images/link_image_blue.jpg" />
<image>
<url>http://libsyn.com/podcasts/neuroscene/images/link_image_blue.jpg</url>
<title>NeuroScene</title>
<link>http://neuroscene.com</link>
</image>
<itunes:explicit>Clean</itunes:explicit>
<item>
<title>Mirror Neurons:  How Do We Connect with Others Through These &#34;Smart Cells?&#34;</title>
<link>http://neuroscene.com/index.php?post_id=344533#</link>
<description><![CDATA[






<p style="margin: 0in 0in 0.0001pt;">To many in the neuroscience
community, mirror neurons represent the biggest discovery of the past twenty
years.&nbsp; These âsmart cells,â which activate when we perform actions and
when we see other people performing the same or complementary actions, seem to
provide us with a common neurobiologic dynamic for our understanding of how we
learn, empathize, and interact socially and culturally with other human beings
at a fundamental level. &nbsp;In addition, mirror neurons may also be the key
to understanding and treating a variety of social interaction disorders such as
autism, social anxiety, and obsessive-compulsive disorders.<u1:p></u1:p><br/></p>
<p style="margin: 0in 0in 0.0001pt;"><br/></p>
<p style="margin: 0in 0in 0.0001pt;">In this
podcast, we speak with <a href="http://faculty.bri.ucla.edu/institution/personnel?personnel_id=46207">Dr. Marco Iacoboni</a>, Director of the Transcranial Magnetic
Stimulation Lab at the <st1:place><st1:placename><st1:place><st1:placename>Ahmanson-Lovelace</st1:placename></st1:place>
 <st1:placename><st1:placename>Brain</st1:placename></st1:placename> <st1:placename><st1:placename>Mapping</st1:placename></st1:placename>
 <st1:placetype><st1:placetype>Center</st1:placetype></st1:placetype></st1:placename></st1:place>
of the David Geffen School of Medicine at UCLA.&nbsp; Dr. Iacoboni is currently
leading some of the most advanced research on the human mirror neuron system
and its role in both social behavior and social disorders.&nbsp; <br/></p>
<p style="margin: 0in 0in 0.0001pt;"><br/></p>
<p style="margin: 0in 0in 0.0001pt;">Be sure to
listen in on this provocative interview where we discuss Dr. Iacoboniâs new
book, <a href="http://us.macmillan.com/mirroringpeople"><i>Mirroring People: The New Science of How We Connect with Others</i></a>
(May 2008, Farrar, Straus and Giroux), and delve into the fascinating details
of one of the most exciting new areas of scientific discovery. <br/></p>
<p style="margin: 0in 0in 0.0001pt;"><br type="_moz"/><o:p></o:p></p>







]]></description>
<category>Cognition</category>
<pubDate>Fri, 30 May 2008 05:02:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=344533#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Marco_Iacoboni_052008.mp3" length="21914981" type="audio/mpeg"/>
<itunes:duration>00:22:48</itunes:duration>
<itunes:keywords>neuroscience, mirror neurons </itunes:keywords>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>Clean</itunes:explicit>
</item>
<item>
<title>The Psychology of Overspending</title>
<link>http://neuroscene.com/index.php?post_id=329767#</link>
<description><![CDATA[Personal credit card debt in the <st1:country-region><st1:place>United
  States</st1:place></st1:country-region> has doubled since 2004, and personal
bankruptcies are at the highest rates ever.<span>&nbsp;
</span>And despite unprecedented levels of economic growth and wealth creation,
the median American family has less than $10,000 in assets.<span>&nbsp; </span>This begs the question, âWhere has all the
money gone?&quot;<br/><br/>The unvarnished truth is that many Americans
spend and continue to spend well beyond their means, in essence mortgaging their
futures for the temporary convenience of the present.<span>&nbsp; </span>And as the <a href="http://en.wikipedia.org/wiki/United_States_housing_bubble"><st1:country-region><st1:place>U.S.</st1:place></st1:country-region>
housing crisis</a><span> </span>continues to intensify, these same individuals are finding
themselves in an increasingly precarious financial predicament brought on by
years of unchecked consumptive habits.<br/><br/>In this program, we speak with <a href="http://www.eng.iastate.edu/tkhira/">Dr.
Tahira K. Hira</a> of <st1:place><st1:placename>Iowa</st1:placename> <st1:placetype>State</st1:placetype>
 <st1:placetype>University</st1:placetype></st1:place>.<span>&nbsp; </span>Dr. Hira is internationally known for her
research in consumer bankruptcy, consumer credit, and the social and
psychological aspects of borrowing among middle and high income Americans as
well as the impact of gambling and credit use on family financial
well-being.<span> </span><br/><br type="_moz"/>

<p style="margin: 0in 0in 0.0001pt;">Join us in this timely and
insightful conversation where we explore the key factors that influence
peopleâs buying and borrowing behavior and help explain why people overspend in
the first place.</p>



<p style="margin: 0in 0in 0.0001pt;"><br/><span> </span></p>



]]></description>
<category>Pleasure</category>
<pubDate>Tue, 15 Apr 2008 02:26:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=329767#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Tahira_K._Hira_040908.mp3" length="27466315" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>Clean</itunes:explicit>
</item>
<item>
<title>Virtual Worlds &#38; False Identities: Social Media or Social Pathology?</title>
<link>http://neuroscene.com/index.php?post_id=309507#</link>
<description><![CDATA[As communications technologies such as <a href="http://en.wikipedia.org/wiki/Second_Life">Second Life</a> become more and
more sensory and interactive, human beings are increasingly being forced to
navigate environments that consistently blur the lines between fantasy and
reality.&nbsp; And while most industry
analysts praise this next big wave of &quot;social media,? a growing number of
neuroscientists are critically analyzing how these &quot;false identities? might
impact us in our &quot;real-life? interactions and relationships.&nbsp;&nbsp; <br/><br/>In this podcast, we are delighted to feature
<a href="http://www.pharm.ox.ac.uk/academics/greenfield">Baroness Susan
Greenfield</a>, one of the world's leading brain researchers and the author of
the upcoming book, <a href="http://www.hodder.co.uk/book_details.asp?book=107058"><span style="font-style: italic;">ID The Quest for Identity in the 21st Century</span></a> (May 2008, Hodder &amp; Stoughton).&nbsp; As the Director of <a href="http://www.rigb.org/registrationControl?action=home">The Royal
Institution of Great Britain</a>
and professor of pharmacology at Oxford
University, her research and writing have advanced our understanding of
the
workings of the human brain and have stimulated public understanding
of, and
appreciation for, that most complex of human organs.&nbsp; And as one of
Great Britain's most popular and recognizable public figures,
Baroness Greenfield has been instrumental in communicating the critical
notion
that the human brain is not only highly adaptive to our changing
technological
landscape, but also highly vulnerable to it as well. <br/><br/>Be sure to tune into this
thought-provoking interview where we look at the latest science of
human/technology interaction and examine how these emerging âvirtual worlds?
are increasingly shaping the human identity.<br/><br type="_moz"/>]]></description>
<category>Cognition</category>
<pubDate>Thu, 21 Feb 2008 02:42:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=309507#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Baroness_Susan_Greenfield_011808.mp3" length="24164438" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Cold Water and Mood Enhancement: A New Potential Therapy for Depression?</title>
<link>http://neuroscene.com/index.php?post_id=301670#</link>
<description><![CDATA[





<p style="margin: 0in 0in 0.0001pt;">Hydrotherapy, or the medicinal use
of water, has long been utilized by both traditional and alternative medicine
to treat a variety of physical ailments.&nbsp;
However, recent scientific studies have suggested that cold water
therapies might be effective in the treatment of mood disorders such as
depression â and that there might actually be an evolutionary basis to
this.</p>
<p style="margin: 0in 0in 0.0001pt;"><br/></p>
<p style="margin: 0in 0in 0.0001pt;">In this program, we speak with Dr.
Nikolai Shevchuk, author of the November 2007 study, <i><a href="http://lib.bioinfo.pl/pmid:17993252">Adapted Cold Shower as a
Potential Treatment for Depression</a>. </i>Dr. Shevchukâs work has been
instrumental in identifying and explaining how cold temperatures activate
specific areas of the brain that appear to be involved with the regulation of
mood in humans.&nbsp; <br/></p>


<p style="margin: 0in 0in 0.0001pt;"><br/></p>


<p style="margin: 0in 0in 0.0001pt;">Join us as we explore
the hard science of cold water therapy and examine how our current âambient
temperatureâ? lifestyle might potentially be a factor in our mood states.<span>&nbsp;&nbsp; </span><span><br/></span></p>
<p style="margin: 0in 0in 0.0001pt;"><span><br/></span></p>




]]></description>
<category>Depression</category>
<pubDate>Tue, 15 Jan 2008 19:48:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=301670#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Nikolai_Shevchuk_011008.mp3" length="14214083" type="audio/mpeg"/>
<itunes:keywords>brain, mind, neuroscience, health, medicine</itunes:keywords>
<itunes:author>NeuroScene</itunes:author>
<itunes:subtitle>Exploring the Future of Neuroscience</itunes:subtitle>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Convection Enhanced Delivery: Brain Drug Therapy Through Direct Tissue Infusion</title>
<link>http://neuroscene.com/index.php?post_id=286759#</link>
<description><![CDATA[

<p>In our previous podcast on the <a href="http://www.neuroscene.com/index.php?post_id=255049">blood brain barrier</a>, we explored the issues and challenges involved with delivering therapeutic
compounds into the brain.<span>&nbsp; </span>And while both
big pharma and academic neuroscience continue to disregard the limiting factors
of the blood brain barrier, a few pioneering companies are tackling this issue
head on.<span>&nbsp; </span><br/></p>



<p>In this segment, we speak with
Stephan Mittermeyer of <a href="http://www.brainlab.com/scripts/website_english.asp">BrainLAB</a>, a medical equipment company headquartered in
Munich, Germany.<span>&nbsp; </span>Stephanâs group has
developed an integrated approach to circumventing the blood brain barrier that involves a process known as c<span lang="EN-GB">onvection enhanced delivery, or
CED.<span>&nbsp; </span>Join us as we explore BrainLABâs <a href="http://www.brainlab.com/scripts/website_english.asp?menuDeactivate=1&articleID=2282&articleTypeID=269&pageTypeID=4&article_short_headline=iPlan%AE%20Flow">innovative
technique</a> for delivering drugs directly into the brain â one that is as much a
tale of physics and engineering as it is of biology.<span>&nbsp; </span><span>&nbsp; </span></span></p>





]]></description>
<category>Trauma</category>
<pubDate>Sat, 1 Dec 2007 04:39:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=286759#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_BrainLAB_113007.mp3" length="14326932" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Are Male and Female Color Preferences &#34;Hardwired?&#34;</title>
<link>http://neuroscene.com/index.php?post_id=273353#</link>
<description><![CDATA[

When two neuroscientists at <a href="http://www.ncl.ac.uk/ion/">Newcastle University</a> in <st1:country-region><st1:place>Great
  Britain</st1:place></st1:country-region> published the results of their study
in the <st1:date year="2007" day="21" month="8">August 21, 2007</st1:date>
edition of the journal <a href="http://www.current-biology.com/content/article/abstract?uid=PIIS096098220701559X">Current
Biology</a>, they were quite surprised at the strong reaction and scrutiny from
the media and the general public.<span>&nbsp; </span>And
what exactly was it that courted such controversy?<span>&nbsp; </span>Specifically, Dr. Anya Hurlbert and Dr. Yazhu
Ling reported research findings that seemed to indicate that there might be consistent
and predictable differences in color preferences between men and women.<span>&nbsp; </span>However, what really âfanned the flamesâ? was
the speculation that these sex differences might be evolutionary and based
upon sex-specific behaviors likely practiced by our ancestors.<span>&nbsp; </span><br/>


<p class="MsoNormal">In this podcast, we go beyond the superficial
controversy and instead delve into the fascinating details of how humans
process and perceive color â and how we might indeed be hardwired to perceive
it in different ways.<span>&nbsp; </span>Join us for a
fascinating and dynamic discussion with Dr. Ling where we explore the real
story at a much deeper and more scientific level.<span>&nbsp; </span></p>










]]></description>
<category>Cognition</category>
<pubDate>Thu, 1 Nov 2007 03:46:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=273353#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Yazhu_Ling_103007.mp3" length="16822985" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Virtual Reality and Rehabilitation: Brain-Computer Interfaces as Therapeutic Tools</title>
<link>http://neuroscene.com/index.php?post_id=259067#</link>
<description><![CDATA[

<p class="MsoNormal"><span>Whenever the topic
of <a href="http://en.wikipedia.org/wiki/Virtual_reality">virtual reality</a> comes up, we tend to automatically think of video games or
science fiction movies.<span>&nbsp; </span>But separate from all this hype and fantasy are dedicated scientists who are using virtual
reality applications to enhance the lives of people suffering from a wide array
of neurological ailments.<span>&nbsp; </span>And the key
factor driving this interest in virtual reality lies in the fact that virtual
reality is much more than merely a visual phenomenon.<span>&nbsp;
</span></span><br/></p>





In this program we speak with <a href="http://www.temple.edu/CHP/faculty/EmilyAKeshner.html">Dr. Emily Keshner</a>, <strong><span style="font-weight: normal;">Professor and Chair</span></strong>,
Department of Physical Therapy and <strong><span style="font-weight: normal;">Professor</span></strong>, Department of Electrical
and Computer Engineering at <st1:place><st1:placetype>Temple</st1:placetype> <st1:placetype>University</st1:placetype></st1:place>.<span>&nbsp; </span>Dr. Keshner is leading research at the
state-of-the-art <a href="http://www.smpp.northwestern.edu/vepo/">Virtual Reality and Postural Orientation
Laboratory</a> that examines how virtual reality influences both the visual and vestibular
systems in human beings â and how these two systems are inextricably linked to
each other.<span>&nbsp; </span><br/>




<p class="MsoNormal">Join us for a fascinating
discussion of virtual reality and how this dynamic visual environment is
proving to be an indispensable rehabilitation tool for patients with all types
of neurological disorders that affect both balance and posture in humans.<span>&nbsp;&nbsp; </span><o:p></o:p></p>







]]></description>
<category>Motion</category>
<pubDate>Mon, 24 Sep 2007 03:28:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=259067#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Emily_Keshner_090607.mp3" length="24329114" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Special Tribute: Dr. Ann E. Kelley</title>
<link>http://neuroscene.com/index.php?post_id=255737#</link>
<description><![CDATA[

<span>When you listen to one
of these shows, youâre really only hearing a very small part of a much greater
effort.<span>&nbsp; </span>By the time a show is officially
âready for prime time,â? Iâve typically spent several weeks â or even months in
some cases â communicating back and forth with each guest.<span>&nbsp; </span>And as much as I try to keep things businesslike, Iâm always surprised at how fairly well I get to know the guest
during this period.<span>&nbsp; </span><o:p></o:p></span>





<p class="MsoNormal"><span>I think there are
two reasons for this.<span>&nbsp; </span>First, with all
the back-and-forth e-mails, phone calls, and appointment (re)schedulings, you
really get a feel for a personâs temperament and personality.<span>&nbsp; </span>Second, both my guest and I are bound by a
strong mutual interest â namely, we are insatiably curious about the inner
workings of the human brain and mind.<span>&nbsp; </span>And
itâs this fascination with exploring the unknown that, I believe, helps us
connect at a much deeper level.<span>&nbsp; </span><o:p></o:p></span></p>






<p class="MsoNormal"><span>I had the great
pleasure of working with Dr. Ann E. Kelley back in late March of 2006.<span>&nbsp; </span>At that time, we were transitioning
NeuroScene towards a syndicated content model, and Dr. Kelley was one of our
first podcast guests.<span>&nbsp; </span>I recall Dr.
Kelley as being an exceptionally bright and engaging individual who had the
rare dual blessings of both loving oneâs field of study â and of being one of
the worldâs best at it.<span>&nbsp; </span><o:p></o:p></span></p>






<p class="MsoNormal"><span>Sadly, Dr. Kelley
lost her battle with cancer last month.<span>&nbsp; </span>As
a tribute to her, we are reposting the original interview, âThe Neuroscience of
Obesity,â? with an updated introduction.<span> </span><o:p></o:p></span></p>






<span><o:p></o:p></span>


]]></description>
<category>Pleasure</category>
<pubDate>Fri, 14 Sep 2007 04:30:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=255737#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Ann_Kelley_033106.mp3" length="25233995" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Blood-Brain Barrier Drug Delivery: Neglecting the Obvious?</title>
<link>http://neuroscene.com/index.php?post_id=255049#</link>
<description><![CDATA[

<p class="MsoNormal"><span>Itâs no secret that
researchers in both the commercial pharma and academic neuroscience communities
are intent on designing new medicines to treat the growing populations of
patients afflicted with central nervous system disorders such as Alzheimerâs
disease, Parkinsonâs disease, stroke, and brain tumors.<span>&nbsp; </span>And itâs also no secret that the biggest
obstacle to the successful delivery of these specialized drug therapies is the <a href="http://en.wikipedia.org/wiki/Blood-brain_barrier">blood brain barrier</a>
â a unique network of tightly packed endothelial cells that </span>protects the
brain from the many chemicals flowing within the blood<span>.<span>&nbsp; </span><o:p></o:p></span></p>







<p class="MsoNormal"><span>Whatâs surprising,
however, is that the blood brain barrier continues to be significantly disregarded
as an essential area of focus within both Big Pharma and the academic neuroscience
establishment.<span>&nbsp; </span>And the unfortunate
byproduct of this neglect is a substantial over funding of neuroscience
research projects that produce few commercially viable therapies that can
effectively address the growing threat of many age-related neurological
conditions.<span>&nbsp; </span><o:p></o:p></span></p>







<p class="MsoNormal">In this program, we speak with <a href="http://faculty.bri.ucla.edu/institution/personnel?personnel_id=45840">Dr.
William Pardridge</a>, Professor of Medicine at the UCLA Brain Research
Institute and founder of <a href="http://www.armagen.com/index.php">ArmaGen
Technologies</a>.<span>&nbsp; </span>Join us for an
eye-opening discussion of the science and politics of blood brain barrier drug
delivery, and learn more about some of the fascinating new areas of research and
development in this critical, but very often overlooked, area of
neuroscience.<span>&nbsp; </span><o:p></o:p></p>





]]></description>
<category>Cognition</category>
<pubDate>Sat, 8 Sep 2007 02:36:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=255049#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._William_Pardridge_082507.mp3" length="20434988" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Nerve Zero: The Key to Subliminal Sexual Attraction?</title>
<link>http://neuroscene.com/index.php?post_id=245729#</link>
<description><![CDATA[





<p style="margin: 0in 0in 0.0001pt;">Is it possible that we humans have a
âsixth senseâ? with regards to sexual attraction and mate selection?<span>&nbsp; </span>This notion may not be as far fetched as it
might seem.<span>&nbsp; </span>While it is well known that chemicals
known as <a href="http://en.wikipedia.org/wiki/Pheromones">pheromones</a>
influence the sexual arousal and breeding behaviors in animals such as insects
and rodents, this connection has never been conclusively established among the
human species.<span>&nbsp; </span><br/></p>



<p style="margin: 0in 0in 0.0001pt;"><br/></p>







<p style="margin: 0in 0in 0.0001pt;">But this may be changing in the
near future.<o:p></o:p></p>



<p style="margin: 0in 0in 0.0001pt;"><br type="_moz"/><o:p></o:p></p>





<p style="margin: 0in 0in 0.0001pt;"><o:p></o:p>The secret to our subliminal sexual
attraction might very well lie with a little known â and rather controversial â
<a href="http://en.wikipedia.org/wiki/Cranial_nerve">cranial nerve</a> known as
â<a href="http://en.wikipedia.org/wiki/Cranial_nerve_zero">nerve zero</a>.â?<span>&nbsp;&nbsp; </span>Although it was discovered back in 1878,
nerve zero has largely been overlooked as a potential conduit for transmitting
human pheromone signals.<span>&nbsp; </span>In fact, you
wonât find even nerve zero referenced in most brain anatomy textbooks.<br/><span>&nbsp;</span><o:p></o:p></p>





<p style="margin: 0in 0in 0.0001pt;">In this program, we speak with <a href="http://neuroscience.nih.gov/Lab.asp?Org_ID=274">Dr. R. Douglas Fields</a>,
<span style="color: black;">Chief of the Nervous System Development and
Plasticity Section, NICHD</span> and adjunct professor at the <st1:place><st1:placetype>University</st1:placetype>
 of <st1:placename>Maryland</st1:placename></st1:place>.<span>&nbsp; </span><span>&nbsp;</span>Dr.
Fields has spearheaded much of the recent research with nerve zero, and
he provides an excellent overview of some of the most recent findings surrounding
this fascinating new area of scientific discovery. <span>&nbsp;</span><span> <br/></span></p>
<p style="margin: 0in 0in 0.0001pt;"><span><br/></span></p>





]]></description>
<category>Pleasure</category>
<pubDate>Mon, 13 Aug 2007 03:19:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=245729#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._R._Douglas_Fields_080807.mp3" length="16391651" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Oxytocin: The Science and Economics of Trust</title>
<link>http://neuroscene.com/index.php?post_id=240163#</link>
<description><![CDATA[





<p class="MsoNormal">What makes one person trust another person?<span>&nbsp; </span>Why do we get a âgut feelingâ? â either good
or bad â about another person whom weâve just met?<span>&nbsp; </span>And how does trust at a micro level in areas
such as business transactions and legal agreements affect the overall economy
and market efficiency of a society?<o:p></o:p></p>









<p class="MsoNormal"><o:p></o:p>In this program, we speak with <a href="http://www.cgu.edu/pages/473.asp">Dr. Paul Zak</a>, a Professor at <st1:place><st1:placename>Claremont</st1:placename>
 <st1:placename>Graduate</st1:placename> <st1:placetype>University</st1:placetype></st1:place>
in <st1:place>Southern California</st1:place> and one of the founders of the
field of <a href="http://en.wikipedia.org/wiki/Neuroeconomics" title="Neuroeconomics">neuroeconomics</a>.</p>









<p class="MsoNormal"><o:p></o:p>Dr. Zakâs research was the first to identify the role of the
neuropeptide <a href="http://en.wikipedia.org/wiki/Oxytocin" title="Oxytocin">oxytocin</a>
in mediating trusting behaviors between unacquainted humans in 2004.<span>&nbsp; </span>In addition to directing the <a href="http://www.neuroeconomicstudies.org/" title="http://www.neuroeconomicstudies.org">Center for Neuroeconomics Studies</a>
at <st1:place><st1:placename>Claremont</st1:placename> <st1:placename>Graduate</st1:placename>
 <st1:placetype>University</st1:placetype></st1:place>, Dr. Zak has an upcoming
book â &quot;Moral Markets: The Critical Role of Values in the Economy&quot; â which will
be soon be available through Princeton University Press in 2007.</p>





<p class="MsoNormal">Join us for a fascinating discussion of <span>neuroeconomics, and how trust and the role
of oxytocin affect us at both an individual and a societal level.</span></p>







]]></description>
<category>Cognition</category>
<pubDate>Sat, 28 Jul 2007 03:56:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=240163#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Paul_Zak_072507.mp3" length="21346975" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>&#34;Dementia of Football&#34;: The Next Major Public Health Issue in Sports?</title>
<link>http://neuroscene.com/index.php?post_id=225593#</link>
<description><![CDATA[

<p class="MsoNormal">On <st1:date year="2002" day="24" month="9"><st1:date year="2002" day="24" month="9">September 24, 2002</st1:date></st1:date>, Pro
Football Hall of Fame center Michael Lewis Webster died in <st1:place><st1:placename><st1:place><st1:placename>Allegheny
  General</st1:placename></st1:place> <st1:placetype><st1:placetype>Hospital</st1:placetype></st1:placetype></st1:placename></st1:place>'s
coronary care unit at age 50.&nbsp; Known as &quot;Iron Mike&quot; during his playing
years, Webster's discipline and overachieving nature helped propel the
Pittsburgh Steelers to four Super Bowl championships.&nbsp; But soon after
retiring in 1990, Webster's life became plagued by debt, depression, family
turmoil, and eventually homelessness.<br/><br/>Through an entirely serendipitous set of
circumstances, forensic pathologist and neuropathologist <a href="http://neoforenxis.com/index.php?option=com_content&task=view&id=21&Itemid=41">Dr.
Bennet Omalu</a> had an opportunity to conduct an extensive examination of Mike
Webster's brain shortly after his death.&nbsp; What Dr. Omalu found was
astonishing.&nbsp; While Mike Webster's brain did not show any outward physical
signs of dementia, at a cellular level his brain resembled that of an
80-year-old advanced dementia patient.</p>



<p class="MsoNormal">Over the next 5 years, Dr. Omalu
conducted post-mortem tests on additional former pro football players, and he
began to notice an emerging pattern which seemed to indicate an entirely different form of progressive chronic traumatic encephalopathy.&nbsp; Termed &quot;Dementia of
Football,&quot; this syndrome was very different from <a href="http://en.wikipedia.org/wiki/Pugilistic_Parkinson%27s_syndrome">dementia
pugilistica</a>, or the boxers' &quot;punch-drunk syndrome.&quot;&nbsp; In contrast, &quot;Dementia
of Football&quot; tended to occur without the presence of any motor symptoms - which
would explain why it would often be misdiagnosed or completely
overlooked.&nbsp; <br/></p>



<p class="MsoNormal">Join us in this fascinating conversation with Dr. Omalu where
we discuss this newly emerging syndrome in detail and ponder what could very
well be one of the next major public health issues to affect athletes - both
amateur and professional - worldwide.<span>&nbsp; </span></p>





]]></description>
<category>Trauma</category>
<pubDate>Fri, 15 Jun 2007 04:11:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=225593#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Bennet_Omalu_061407.mp3" length="31399729" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Neuroscience and National Defense: Science Fiction or Science Fact?</title>
<link>http://neuroscene.com/index.php?post_id=215690#</link>
<description><![CDATA[

<p class="MsoNormal">In the decades following World War II, a
&quot;military-academic complex&quot; has emerged and has been quite active in
exploring the potential uses of advanced neuroscience applications for our
national defense.&nbsp; But the underlying motives have been fairly consistent
- namely, how can we as a nation harness the power of the human nervous system
in order to gain a strategic advantage over our adversaries?&nbsp; <br/>
<br/>
In his groundbreaking new book, <a href="http://www.dana.org/news/danapressbooks/detail.aspx?id=3272">Mind Wars:
Brain Research and National Defense</a>, <a href="http://www.americanprogress.org/experts/MorenoJonathan.html">Dr. Jonathan
D. Moreno</a> delves into the fascinating origins of our government's
neuroscience and neurotechnology initiatives and provides a detailed glimpse
into what might be the next major frontier of our national defense.&nbsp; <br/>
<br/>
Be sure to join us in this compelling podcast interview with Dr. Moreno where
we discuss both the past history of neuroscience defense initiatives as well as
some of the more exciting potential future developments.&nbsp; From cognitively
enhanced soldiers, to brain-machine interface devices, to non-lethal
neuro-disruption technologies, we take a look at the both the fact and fiction surrounding this cutting-edge area of research.<span style="font-size: 10pt; font-family: Arial;">&nbsp; <br/>
&nbsp;</span></p>






]]></description>
<category>Cognition</category>
<pubDate>Tue, 15 May 2007 05:43:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=215690#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Jonathan_Moreno_051407.mp3" length="18344774" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Is the &#34;Stone Age&#34; Lifestyle the Answer to Eliminating Depression?</title>
<link>http://neuroscene.com/index.php?post_id=211972#</link>
<description><![CDATA[Why is it that, despite unprecedented levels of affluence
and advancement in both medicine and technology, we still see skyrocketing
rates of clinical depression within the developed world?&nbsp; Could it be that we
have altered our environment so radically over the past 60 years - and that our
&quot;hunter-gatherer&quot; genetics just simply have not caught up with these
changes?<br/><br/>Join us in this fascinating conversation with <a href="http://www.psych.ku.edu/psych_people/faculty_Stephen_Ilardi.shtml">Dr. Stephen Ilardi</a> of the <st1:place><st1:placetype>University</st1:placetype>
 of <st1:placename>Kansas</st1:placename></st1:place> where we discuss in
detail what may be the true cause of depression in our society - and how we
might ultimately be able to reclaim those protective &quot;Stone Age&quot; elements that
have historically insulated us from depression since time immemorial.<br/><br/>Program highlights include: <b><br/><br/>(0:50) Overview of evolutionary psychology - </b>why are we genetically &quot;wired&quot; to thrive in a Stone Age environment<b><br/><br/>(4:25<span>) The environmental changes over the last 60 years</span></b> - why
clinical depression is so rare in contemporary hunter-gatherer societies<br/><br/><b>(</b><b>11:10<span>) Socialization and a sense of community</span></b> - how this is missing
from our lives right now, and why this is so important to preventing depression<br/><br/><b>(</b><b>14:55<span>) Physical activit</span>y</b> - why exercise is such a powerful
antidepressant, and how we've engineered this critical activity out of our
lives<br/><br/><span style="font-weight: bold;">(</span><b>22:10<span>) Sleep, sunlight, and circadian rhythms</span></b> - how our current
environment has actually &quot;miscalibrated&quot; our brains to the detriment of
our health<br/><br/><b>(28:45) Diet and consumption patterns</b> - the importance of Omega-3 in
preventing depression, and why we currently no longer consume this essential
supplement in adequate amounts<br/><br/><b>(38:00) The reaction from the scientific community </b>- why many of these statistically
significant findings have been largely ignored by the conventional medical establishment<br/><br/><b>(41:25) The danger of rumination</b> - how our lifestyles have changed so
much that this unhealthy activity is now ubiquitous, and why this factor was relatively
absent in Stone Age societies<br/><br/><b>(48:30) &nbsp;Depression among the younger population</b> - how their
current upbringing is set to predispose these future generations to
skyrocketing levels of depression<br/><br/><b>(53:40)&nbsp; </b><a href="http://www.psych.ku.edu/tlc/" style="font-weight: bold;">&quot;Therapeutic Lifestyle Change&quot;</a><span style="font-weight: bold;"> </span>- how people can reclaim
the six protective lifestyle elements and incorporate them into their current
lives to insulate themselves from depression

<br/><br type="_moz"/>]]></description>
<category>Depression</category>
<pubDate>Sun, 15 Apr 2007 04:47:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=211972#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_Dr._Stephen_Ilardi_041507.mp3" length="54058132" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Ketamine: The Next &#34;Blockbuster&#34; Therapy for Depression?</title>
<link>http://neuroscene.com/index.php?post_id=198796#</link>
<description><![CDATA[Ketamine has a long history of clinical usage and is known for its
effective anesthetic properties.&nbsp; However, ketamine has gained a fair amount of notoriety in recent years as a recreational &quot;club drug&quot; due to its dissociative side effects.&nbsp; <br/><br/>But in the midst of this controversy, ketamine is quietly emerging as the forerunner of what promises to be the next big frontier in treating depression.<br/><br/>According to the World Health Organization, depression affects over 120 million people worldwide, making it the fourth largest contributor to the global burden of disease.&nbsp; And until relatively recently, much of the current focus on treating depression has centered upon compounds and derivatives which interact with the <a href="http://en.wikipedia.org/wiki/Serotonin">serotonin</a> system.&nbsp; Ketamine, by contrast, works directly on the <a href="http://en.wikipedia.org/wiki/Glutamate">glutaminergic system</a>, specifically on the <a href="http://en.wikipedia.org/wiki/NMDA_Receptor_Antagonists">NMDA receptor</a> sites.&nbsp; And the treatment results tend to be much more immediate - and sometimes even profound.&nbsp; <br/><br/>We are very excited to feature <a href="http://www.med.yale.edu/psych/faculty/krystal.html">Dr. John Krystal</a> on this segment.&nbsp; Dr. Krystal has been one of the most influential researchers studying the role that the neurotransmitter glutamate plays in various mood disorders.&nbsp; Join us in this fascinating program as we discuss the emerging role of ketamine as a viable treatment for depression - and how this new scientific focus just might be the next target of &quot;Big Pharma.&quot;&nbsp; <br/><br/><br/>]]></description>
<category>Depression</category>
<pubDate>Sun, 1 Apr 2007 14:34:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=198796#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_109_-_Dr._John_Krystal.mp3" length="25781940" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Science and Commerce of Smell</title>
<link>http://neuroscene.com/index.php?post_id=192079#</link>
<description><![CDATA[Why is it that certain odors or scents can bring up such vivid memories of our past?&nbsp; And why is it that specific smells can significantly alter our moods and perceptions - sometimes without us even being aware that this is taking place?<br/><br/>We are very excited to feature an exclusive interview with Dr. Alan Hirsch of the <a href="http://www.scienceofsmell.com/scienceofsmell/index.cfm?action=promo&pc=soshome3">Smell and Taste Research Foundation</a> in Chicago, IL.&nbsp; Dr. Hirsch has been on the forefront of clinical research studying the complex effects that our senses of smell and taste exert over our everyday lives.&nbsp; From impacting eating patterns, to reducing chronic pain, to even affecting the sexual arousal of us and our romantic partners, we are subtly influenced by the scents and odors in our immediate environment.&nbsp; <br/><br/>Join us in this very compelling discussion where Dr. Hirsch details the research he has done in this area and highlights both the commercial and personal value of his findings.&nbsp; <br/><br/>]]></description>
<category>Cognition</category>
<pubDate>Fri, 16 Mar 2007 01:23:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=192079#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_108_-_Dr._Alan_Hirsch.mp3" length="22513081" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>Ketamine and Chronic Pain:  Is There Finally a Cure for CRPS?</title>
<link>http://neuroscene.com/index.php?post_id=192064#</link>
<description><![CDATA[Our guest on this segment is <a href="http://www.drexelmed.edu/DepartmentsCentersandInstitutes/ClinicalDepts/Neurology/Faculty/RobertJSchwartzman/tabid/1335/Default.aspx">Dr. Robert Schwartzman</a>, professor and chair of the Department of Neurology at the Drexel University College of Medicine.&nbsp; <br/><br/>Over
the past couple of years, Dr. Schwartzman and his colleagues in Germany
have used ketamine to successfully treat patients suffering from the
chronic pain disorder known as <a href="http://www.ninds.nih.gov/disorders/reflex_sympathetic_dystrophy/detail_reflex_sympathetic_dystrophy.htm">complex regional pain syndrome (CPRS)</a>.&nbsp; This pioneering approach is not for the faint of heart.&nbsp; Advanced CPRS patients are actually placed in a ketamine-induced coma for several days.&nbsp; But the results have been
dramatic - often allowing for a complete cure for what had previously been a totally disabling illness*.&nbsp; <br/><br/>Be sure to tune in to this fascinating interview where we discuss both the hard science of the human pain response as well as Dr. Schwartzman's cutting-edge therapeutic approach to treating chronic pain.<br/><br/>* Be sure to also check out the <a href="http://www.rsdfoundation.org/StreamingVideoFilesWMV/CNNvideo/CNN_352K.wmv">CNN video coverage</a> of this study.&nbsp; <br/><br/>]]></description>
<category>Pain</category>
<pubDate>Fri, 2 Mar 2007 01:56:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=192064#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_107_-_Dr._Robert_Schwartzman.mp3" length="37592212" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Psychology of Seduction</title>
<link>http://neuroscene.com/index.php?post_id=181899#</link>
<description><![CDATA[<p class="MsoNormal">It's Valentine's Day, and we couldn't imagine a more
appropriate show! <br/>
<br/>
We are very excited to feature an exclusive interview with Dr. Raj Persaud, a
worldwide authority on the topic, and the author of the psychological
bestseller &quot;<a href="http://www.amazon.co.uk/Simply-Irresistible-Psychology-Seduction-Perfect/dp/0593055888/sr=8-1/qid=1171435025/ref=pd_ka_1/203-1840788-1902345?ie=UTF8&s=books">Simply
Irresistible - The Psychology of Seduction - How to Catch and Keep Your Perfect
Partner</a>.&quot;<br/>
<br/>
Dr. Persaud is Gresham Professor for Public Understanding of Psychiatry and
Consultant Psychiatrist at The Bethlem Royal Hospital - the oldest psychiatric
hospital in the <st1:country-region><st1:place>UK</st1:place></st1:country-region>.&nbsp;
He has won numerous academic prizes and awards for his clinical and research
work including an unprecedented two of the Royal College of Psychiatrist's top
prizes - the Research Prize and Medal and the Morris Markow Prize, as well as
the ancient Society of of Apothecaries' Osler Medal.&nbsp; <br/>
<br/>
A prolific researcher, author, and broadcaster, Dr. Persaud presents a series
of podcasts on the <a href="http://www.rcpsych.ac.uk/default.aspx?page=0">Royal
College Website</a> and is the author of over 150 research and academic
papers.&nbsp; <i>The Times </i>newspaper recently voted him one of the top
twenty gurus in the world and <i>The Independent </i>also recently elected him
one of the top ten clinical psychiatrists in the <st1:country-region><st1:place>UK</st1:place></st1:country-region>
- the youngest doctor to make it onto this esteemed list.&nbsp;</p>

]]></description>
<category>Pleasure</category>
<pubDate>Wed, 14 Feb 2007 07:00:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=181899#</guid>
<author>steve@neuroscene.com</author>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_106_-_Dr._Raj_Persaud.mp3" length="27592121" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:subtitle>Innovators in Neuroscience</itunes:subtitle>
<itunes:explicit>Clean</itunes:explicit>
</item>
<item>
<title>How Video Games Satisfy Intrinsic Human Needs</title>
<link>http://neuroscene.com/index.php?post_id=180820#</link>
<description><![CDATA[The market for video and PC games has accelerated so rapidly within the past few years that this industry has now eclipsed Hollywood in both size and revenue.&nbsp; And with the increasing popularity of Massively Multiplayer Online Role-Playing Games (MMORPGs) like <a href="http://secondlife.com/">Second Life</a>, these entertainment mediums are attracting audiences of all age groups and demographics.&nbsp; <br/><br/>In this interview with Dr. Scott Rigby of <a href="http://www.immersyve.com/about-immersyve/">Immersyve</a>, we explore the underlying human motivations that have been driving this commercial phenomenon.&nbsp; Instead of automatically condemning video games as &quot;addictive&quot; or &quot;time wasting,&quot; we take the subject to a much deeper level - and we try to nail down what this really means to businesses in this market space.&nbsp; (Originally broadcast 10-January-2007)<br/><br/>]]></description>
<category>Pleasure</category>
<pubDate>Thu, 1 Feb 2007 19:03:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180820#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_105_-_Immersyve.mp3" length="28759481" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>CCF Innovations Neuroscience Summit</title>
<link>http://neuroscene.com/index.php?post_id=180811#</link>
<description><![CDATA[All the &quot;big guns&quot; in neuroscience will be getting together within the next few weeks at the Cleveland Clinic Medical Innovation Summit.&nbsp; Get the inside scoop on the hottest areas of neuroscience research and commercial development from Chris Coburn, the Executive Director of <a href="http://www.clevelandclinic.org/innovations/default.htm">CCF Innovations,</a> the commercialization arm of the Cleveland Clinic Foundation.&nbsp; (Originally broadcast 24-October-2006)<br/><br/>]]></description>
<category>podcasts</category>
<pubDate>Mon, 15 Jan 2007 18:32:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180811#</guid>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_104_-_Cleveland_Clinic.mp3" length="19765417" type="audio/mpeg"/>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Neuroscience of Obesity</title>
<link>http://neuroscene.com/index.php?post_id=180799#</link>
<description><![CDATA[The phrase &quot;junk food junkie&quot; might be closer to the truth than you realize.&nbsp; Scientists are just beginning to uncover some of the neural mechanisms which underlie food cravings and overeating.&nbsp; Learn more about the neuroscience of obesity in this fascinating podcast interview with <a href="http://www.psychiatry.wisc.edu/faculty/FacultyPages/Kelley.htm">Dr. Ann E. Kelley</a> of the University of Wisconsin.&nbsp; (Originally broadcast 31-March-2006)<br/><br/>]]></description>
<category>Pleasure</category>
<pubDate>Wed, 3 Jan 2007 18:26:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180799#</guid>
<author>steve@neuroscene.com</author>
<enclosure url="http://media.libsyn.com/media/neuroscene/NeuroScene_Podcast_102_-_Dr._Anne_Kelley.mp3" length="25740562" type="audio/mpeg"/>
<itunes:duration>00:26:48</itunes:duration>
<itunes:keywords>neuroscience, commerical,</itunes:keywords>
<itunes:author>NeuroScene</itunes:author>
<itunes:subtitle>Neuroscience Innovators</itunes:subtitle>
<itunes:explicit>Clean</itunes:explicit>
</item>
<item>
<title>About NeuroScene</title>
<link>http://neuroscene.com/index.php?post_id=180870#</link>
<description><![CDATA[<br/><span style="font-weight: bold;">Welcome to NeuroScene, where we explore the future of neuroscience</span><span style="font-style: italic; font-weight: bold;">...<br/><br/></span>NeuroScene is the producer of the groundbreaking podcast series &quot;<span style="font-style: italic;">Innovators in Neuroscience</span>&quot; which is syndicated globally on the World Wide Web.&nbsp; Since 2004, 
we have been providing readers and site visitors with the most
comprehensive, cutting-edge information on the key trends and the hottest new developments within this industry space.&nbsp; From breaking news stories to in-depth special reports, NeuroScene gives you the inside word on one of science's most fascinating frontiers.&nbsp; <br/><br/><hr style="width: 100%; height: 2px;"/><br/><span style="font-weight: bold;">Do you want to be a guest on our show?&nbsp; </span><br/><br/>NeuroScene is always on the lookout for interesting stories or topics to highlight on a future show.&nbsp; If you have a great story or area of research that the world needs to hear about, then don't be shy about contacting us directly!&nbsp; <br/><br/>You can call us at (312) 376-8099 or send an e-mail to steve@neuroscene.com.&nbsp; Please tell us about yourself, why you would like to be featured on NeuroScene, and provide us with your contact information and when you are available for an interview.<br/>&nbsp; <br/><span style="font-weight: bold;">What you can expect during this process:  </span><br/><br/>Once we confirm your participation as a guest on the show, we will put together a tentative program outline which you would then review and revise as you see fit.&nbsp; If there is any particular area that you might want to emphasize or expand upon, we would go with that.<br/><br/>The majority of our interviews are conducted over the phone and are edited and mixed afterwards. &nbsp;If a guest wants to rephrase an answer to a question or remove any part of the interview, this can easily be done prior to the actual broadcast.&nbsp; The podcasts are then distributed worldwide via numerous syndicated media outlets.<br/><br/>Above all, our goal is make sure that you and your ideas are presented in the best possible way to the neuroscience community and to the general public.&nbsp; By keeping the dialogue both informative and lively, we allow you to provide our listeners and subscribers with the most advanced knowledge and information on the fascinating field of neuroscience.&nbsp; <br/><br/><hr style="width: 100%; height: 2px;"/><br/><span style="font-weight: bold;">Press information:</span>&nbsp; We have a press-friendly policy, and we are happy to work with or share knowledge with other members of the media.&nbsp; Call or e-mail, and we'll find a way to help you.&nbsp; Deadlines understood.&nbsp; <br/><br/><span style="font-weight: bold;">Editorial integrity policy:</span>&nbsp; As an Internet-enabled media company, we support our work with related income.&nbsp; We believe the ethical response is to make clear where our conflicts of interest might be.&nbsp; Like most trade media, we accept advertising and occasional contracted consulting work from companies within the industry.&nbsp; We believe we serve our advertisers best by independent reporting that attracts readers to their ads.&nbsp; <br/><br/><span style="font-weight: bold;">Privacy policy:</span>&nbsp; We do not collect any information about visitors to our site other than website statistics.&nbsp; We do not share our industry contact lists with anyone, although infrequently we will do a mailing on behalf of a sponsor.&nbsp; <br/><br/><br/><br/>]]></description>
<category>About NeuroScene</category>
<pubDate>Tue, 2 Jan 2007 20:24:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180870#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Trauma Market</title>
<link>http://neuroscene.com/index.php?post_id=180860#</link>
<description><![CDATA[<span style="font-weight: bold;">Trauma </span>refers to a serious or critical bodily injury, wound, or shock which often results in lasting mental and physical effects.&nbsp; <br/><br style="font-weight: bold;"/><span style="font-weight: bold;">Major therapeutic categories:</span><br/><br/>- Stroke<br/>- Traumatic brain injury<br/>- Epilepsy<br/>- Cerebral hypoxia<br/>- Meningitis<br/><br/>Bottom line:<br/><br/><span style="font-weight: bold;">Patients (US): 12,700,000</span><br style="font-weight: bold;"/><span style="font-weight: bold;">Direct medical spending: US$ 128.9 billion</span><br/>]]></description>
<category>Trauma</category>
<pubDate>Mon, 1 Jan 2007 20:18:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180860#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Motion Market</title>
<link>http://neuroscene.com/index.php?post_id=180859#</link>
<description><![CDATA[<span style="font-weight: bold;">Motion </span>refers to a voluntary or involuntary physical action or a change in the speed, fluency, quality, and ease of movement or mobility.&nbsp; <br/><br/><span style="font-weight: bold;">Major therapeutic categorties:</span><br/><br/>- Parkinson's disease<br/>- Huntington's disease<br/>- Restless leg syndrome<br/>- Benign paroxysmal positional vertigo (BPPV)<br/>- Dysphagia<br/><br/><span style="font-weight: bold;">Bottom line:</span><br style="font-weight: bold;"/><br style="font-weight: bold;"/><span style="font-weight: bold;">Patients (US): 28,000,000</span><br style="font-weight: bold;"/><span style="font-weight: bold;">Direct medical spending: US$ 60.7 billion </span><br style="font-weight: bold;"/><br/>]]></description>
<category>Motion</category>
<pubDate>Mon, 1 Jan 2007 20:12:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180859#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Cognition Market</title>
<link>http://neuroscene.com/index.php?post_id=180855#</link>
<description><![CDATA[<span style="font-weight: bold;">Cognition </span>refers to the mental processes of an individual such as memory, attention, perception, action, problem solving, and mental imagery - all of which contribute towards optimal sensory and information processing.<br/><br/><span style="font-weight: bold;">Major therapeutic categories:</span><br/><br/>- Alzheimer's disease<br/>- Schizophrenia<br/>- Attention deficit hyperactivity disorder<br/>- Vascular dementia<br/>- Speech &amp; language disorders<br/><br/><span style="font-weight: bold;">Bottom line:</span><br style="font-weight: bold;"/><br style="font-weight: bold;"/><span style="font-weight: bold;">Patients (US) - 19,300,000</span><br style="font-weight: bold;"/><span style="font-weight: bold;">Direct medical spending - US$ 128.8 billion</span><br/>]]></description>
<category>Cognition</category>
<pubDate>Mon, 1 Jan 2007 20:06:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180855#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Pleasure Market</title>
<link>http://neuroscene.com/index.php?post_id=180852#</link>
<description><![CDATA[<span style="font-weight: bold;">Pleasure </span>is a present, positive sensory and emotional experience involving a feeling of delight, comfort, or gratification.&nbsp; <br/><br style="font-weight: bold;"/><span style="font-weight: bold;">Major therapeutic categories:</span><br/><br/>- Addiction disorders<br/>- Recreational substance abuse<br/>- Sexual desire &amp; enhancement<br/><br/><span style="font-weight: bold;">Bottom line:</span><br style="font-weight: bold;"/><br style="font-weight: bold;"/><span style="font-weight: bold;">Patients (US) - unknown</span><br style="font-weight: bold;"/><span style="font-weight: bold;">Direct medical spending - undefined</span><br/>]]></description>
<category>Pleasure</category>
<pubDate>Mon, 1 Jan 2007 20:02:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180852#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Pain Market</title>
<link>http://neuroscene.com/index.php?post_id=180851#</link>
<description><![CDATA[<span style="font-weight: bold;">Pain </span>is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.&nbsp; <br/><br/><span style="font-weight: bold;">Major therapeutic categories:</span><br/><br/>- Acute pain management<br/>- Chronic pain management<br/>- Migraine headache disorder<br/><br/><span style="font-weight: bold;">Bottom line:</span><br style="font-weight: bold;"/><br style="font-weight: bold;"/><span style="font-weight: bold;">Patients (US) - 103,000,000</span><br style="font-weight: bold;"/><span style="font-weight: bold;">Direct medical spending - US$ 43 billion</span><br/>]]></description>
<category>Pain</category>
<pubDate>Mon, 1 Jan 2007 19:56:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180851#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Fatigue Market</title>
<link>http://neuroscene.com/index.php?post_id=180847#</link>
<description><![CDATA[<span style="font-weight: bold;">Fatigue </span>is a state, following a period of mental or physical activity, characterized by a lessened capacity for work and a reduced efficiency of accomplishment, usually accompanied by a feeling of weariness, sleepiness, or irritability.&nbsp; <br/><br/><span style="font-weight: bold;">Major therapeutic categories:</span><br/><br/>- Insomnia<br/>- Sleep deprivation<br/>- Chronic fatigue syndrome<br/><br/>Bottom line:<br/><br style="font-weight: bold;"/><span style="font-weight: bold;">Patients (US) - 70,000,000</span><br style="font-weight: bold;"/><span style="font-weight: bold;">Direct medical spending - US$ 15.9 billion</span><br/>]]></description>
<category>Fatigue</category>
<pubDate>Mon, 1 Jan 2007 19:48:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180847#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Depression Market</title>
<link>http://neuroscene.com/index.php?post_id=180839#</link>
<description><![CDATA[<span style="font-weight: bold;">Clinical depression</span> is a mood disorder in which feelings of sadness, loss, anger, or frustration interfere with everyday life for an extended time.<br/><br/><span style="font-weight: bold;">Major therapeutic categories:</span><br/><br/>- Major depressive disorder<br/>- Bipolar disorder<br/>- Dysthymia<br/><br/><span style="font-weight: bold;">Bottom Line:</span><br style="font-weight: bold;"/><br style="font-weight: bold;"/><span style="font-weight: bold;">Patients (US) - 18,800,000</span><br style="font-weight: bold;"/><span style="font-weight: bold;">Direct medical spending - US$ 30 billion</span><br/>]]></description>
<category>Depression</category>
<pubDate>Mon, 1 Jan 2007 19:41:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180839#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
<item>
<title>The Anxiety Market</title>
<link>http://neuroscene.com/index.php?post_id=180833#</link>
<description><![CDATA[<span style="font-weight: bold;">Anxiety disorder</span> is a blanket term covering several different forms of abnormal anxiety, fear, phobia, and nervous conditions that come on suddenly and prevent pursuing normal daily routines.&nbsp; <br/><br/><span style="font-weight: bold;">Major therapeutic categories:<br/><br/></span>- Generalized anxiety disorder<br/>- Obsessive-compulsive disorder<br/>- Panic disorder<br/>- Post-traumatic stress disorder<br/>- Social anxiety<br/>- Specific phobias<br/><br/><span style="font-weight: bold;">Bottom line:</span><br style="font-weight: bold;"/><br style="font-weight: bold;"/><span style="font-weight: bold;">Patients (US) - 19,100,000</span><br style="font-weight: bold;"/><span style="font-weight: bold;">Direct medical spending - US$ 22.84 billion </span><br/><br/><br/>]]></description>
<category>Anxiety</category>
<pubDate>Mon, 1 Jan 2007 19:29:00 GMT</pubDate>
<guid isPermaLink="true">http://neuroscene.com/index.php?post_id=180833#</guid>
<itunes:author>NeuroScene</itunes:author>
<itunes:explicit>No</itunes:explicit>
</item>
</channel></rss>
